GLP‑1 Medications Trigger Weight Loss and Reverse Depression‑Like Behavior in Mice

Recent research reported that GLP‑1 drugs caused significant weight loss in mice. The same treatment also reversed depression‑like behaviors in the animal subjects. The study examined the gut‑brain axis effects of the medication. Findings suggest a link between metabolic regulation and mood. The results were published in a psychology‑focused outlet. Researchers propose further investigation in human trials. The work could inform future treatments for obesity and depression. The scientific community will watch for follow‑up studies.